Evidence map›Paper›PMID 36187963›Full record

ArticleFrontiers in microbiology2022

Genomic and evolutionary characteristics of G9P[8], the dominant group a rotavirus in China (2016-2018).

Xiafei Liu, Mengxuan Wang, Shan Li, Jingxin Li, Jinbo Xiao, Huiying Li, Qing Zhang, Xiangyu Kong, Hong Wang, Dandi Li and 1 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiafei LiuChinese Center for Disease Control and Prevention, National Institute for Viral Diseases Control and Prevention, Beijing, China.
Mengxuan WangChinese Center for Disease Control and Prevention, National Institute for Viral Diseases Control and Prevention, Beijing, China.
Shan LiChinese Center for Disease Control and Prevention, National Institute for Viral Diseases Control and Prevention, Beijing, China.
Jingxin LiChinese Center for Disease Control and Prevention, National Institute for Viral Diseases Control and Prevention, Beijing, China.
Jinbo XiaoChinese Center for Disease Control and Prevention, National Institute for Viral Diseases Control and Prevention, Beijing, China.
Huiying LiChinese Center for Disease Control and Prevention, National Institute for Viral Diseases Control and Prevention, Beijing, China.
Qing ZhangChinese Center for Disease Control and Prevention, National Institute for Viral Diseases Control and Prevention, Beijing, China.
Xiangyu KongChinese Center for Disease Control and Prevention, National Institute for Viral Diseases Control and Prevention, Beijing, China.
Hong WangChinese Center for Disease Control and Prevention, National Institute for Viral Diseases Control and Prevention, Beijing, China.
Dandi LiChinese Center for Disease Control and Prevention, National Institute for Viral Diseases Control and Prevention, Beijing, China.
Zhaojun DuanChinese Center for Disease Control and Prevention, National Institute for Viral Diseases Control and Prevention, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G9P[8] became the predominant rotavirus A (RVA) genotype in China in 2012. To evaluate its genetic composition at the whole-genome level, 115 G9P[8] RVA strains isolated from children under 5 years old were sequenced and characterized. All 13 strains in 2016 and 2017 and an additional 54 strains in 2018 were genotyped as G9-P[8]-I1-R1-C1-M1-A1-N1-T1-

Indexed as

Bayesian analysisChinaG9P[8]rotaviruswhole-genome

Identifiers

PMID36187963
PMCPMC9522900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.